Genzyme Corp.

Public Company, Headquarters Location
500 Kendall St., Cambridge, MA 02142-1108, United States
(617)252-7500, (617)252-7600 fax, http://www.genzyme.com

Primary SIC: Biological Products Except Diagnostic, Primary NAICS: Biological Product (except Diagnostic) Manufacturing
Description: Genzyme Corporation was founded in Delaware in 1981, and reincorporated as a Massachusetts corporation in 1991. It is a global biotechnology company organized into four reporting segments that each develop, manufacture and distribute specialized products: genetic diseases, cardiometabolic and renal, biosurgery and hematologic oncology. The genetic diseases segment specializes in therapeutic products that treat patients suffering from genetic diseases and other chronic debilitating diseases. The cardiometabolic and renal segment specializes in products designed to treat patients suffering from renal diseases, including chronic renal failure, and endocrine and cardiovascular diseases. The biosurgery segment specializes in biotherapeutics and biomaterial-based products, with an emphasis on products that meet medical needs in the orthopaedics and broader surgical areas. The hematologic oncology segment specializes in products for the treatment of cancer. In addition to these reporting segments, the company also develops, manufactures and markets transplant-related products and genetics testing for the oncology, prenatal and reproductive markets. The company distributes its products globally, and has its major facilities in the U.S., the U.K., Ireland, the Netherlands, Belgium, France, Canada, Switzerland, Germany and Australia. Its major brands include Cerezyme, Fabrazyme, Myozyme, Hectorol, Thyrogen. Synvisc, Carticel, Campath, Mozobil, Clolar and Evoltra. More

Manufacturing: Biotherapeutics, diagnostic products, pharmaceuticals and fine chemicals. Services: Diagnostic services.